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 Caffeine Ingestion Enhances Repetition Velocity  
in Resistance Exercise: A Randomized, Crossover, Double-Blind 
Study Involving Control and Placebo Conditions 
by 
Jozo Grgic1, Sandro Venier2, Brad J. Schoenfeld3, Pavle Mikulic2 
We aimed to examine the effects of placebo and caffeine compared to a control condition on mean velocity in the 
bench press exercise. Twenty-five resistance-trained men participated in this randomized, crossover, double-blind 
study. The participants performed the bench press with loads of 50%, 75%, and 90% of one-repetition maximum 
(1RM), after no supplementation (i.e., control), and after ingesting caffeine (6 mg/kg), and placebo (6 mg/kg of 
dextrose). At 50% 1RM, there was a significant effect of caffeine on mean velocity compared to control (effect size [ES] 
= 0.29; p = 0.003), but not when compared to placebo (ES = 0.09; p = 0.478). At 75% 1RM, there was a significant 
effect of caffeine on mean velocity compared to placebo (ES = 0.34; p = 0.001), and compared to control (ES = 0.32; p < 
0.001). At 90% 1RM, there was a significant effect of caffeine on mean velocity compared to placebo (ES = 0.36; p < 
0.001), and compared to control (ES = 0.46; p < 0.001). There was no significant difference between placebo and control 
in any of the analyzed outcomes. When evaluated pre-exercise and post-exercise, 20% to 44% and 28% to 52% of all 
participants identified caffeine and placebo trials beyond random chance, respectively. Given that the blinding of the 
participants was generally effective, and that there were no significant ergogenic effects of placebo ingestion, the 
improvements in performance following caffeine ingestion can be mainly attributed to caffeine’s physiological 
mechanisms of action. 
Keywords: ergogenic aid; supplements; mean repetition velocity.  
 
Introduction 
Caffeine is one of the most commonly 
ingested psychoactive substances in the world 
(Mitchell et al. 2014). A national survey from the 
U.S. indicated that 85% of the population ingests 
at least one caffeinated beverage per day (Mitchell 
et al. 2014). Caffeine is also a well-researched 
ergogenic aid, with relevant studies dating back 
to 1907 (Rivers and Webber, 1907). For research 
purposes, caffeine is generally ingested in doses 
from 3 to 6 mg/kg, approximately 60 minutes 
before exercise (Grgic et al. 2020a). Current 
evidence indicates that caffeine ingestion, 
compared to placebo, may acutely enhance 
muscle and aerobic endurance, muscle strength, 
and power, as well as speed and jumping 
performance (Grgic et al. 2020a). 
Generally, studies that explore the effects 
of caffeine on exercise performance include two 
trials. In one trial, the participants consume the 
caffeine dose, while in the other, they consume a 
placebo. It is assumed that placebo ingestion does 
not influence exercise test results, so any increases 
in performance are attributed to caffeine's 
physiological mechanisms. However, there are 
several instances where isolated placebo ingestion 
provided an ergogenic effect (Beedie and Foad, 
2009). For example, Pollo et al. (2008) found that 
placebo administration (along with the suggestion 
that it was caffeine), enhanced total work  
178  Caffeine ingestion enhances repetition velocity in resistance exercise 
Journal of Human Kinetics - volume 74/2020 http://www.johk.pl 
 
in a set of leg extensions. Duncan et al. (2009) used 
a design where the researchers informed 
participants that they ingested caffeine on one 
occasion and placebo on another, even though 
they ingested placebo in both cases. Increases in 
muscle endurance were observed when the 
participants thought that they ingested caffeine. 
Given that placebo may enhance performance, 
researchers have suggested that future studies 
should include a non-supplement, control trial in 
their designs (Beedie et al. 2018). A study that 
includes all three trials (i.e., caffeine, placebo, and 
control) would inform and quantify the isolated 
effects of caffeine and placebo on exercise 
performance (Beedie et al. 2018). 
A recent meta-analysis found a significant 
ergogenic effect of caffeine ingestion on repetition 
velocity in resistance exercise (Raya-González et 
al. 2020). However, all 12 studies included in the 
meta-analysis only compared the effects of 
caffeine vs. placebo. In other words, no available 
studies explored the isolated effects of caffeine 
and placebo on repetition velocity. Accordingly, 
we aimed to examine the effects of placebo and 
caffeine compared to a control condition on mean 
repetition velocity in resistance exercise. Based on 
previous research (Duncan et al. 2009; Pollo et al. 
2008), we hypothesized that caffeine and placebo 
ingestion would enhance performance compared 
to a control condition. 
Methods 
Design and Procedures 
This study employed a randomized, 
crossover, double-blind study design, where the 
participants were required to visit the laboratory 
on four occasions. In the first visit, the 
participants filled out a validated questionnaire 
for estimating their habitual caffeine intake 
(Bühler et al. 2014). In line with the validation 
study, this questionnaire utilized a 24-hour recall 
for the assessment of habitual caffeine intake 
(Bühler et al. 2014). Additionally, one-repetition 
maximum (1RM) in the bench press was 
estimated using the methods by Balsalobre-
Fernández et al. (2018). The participants were also 
familiarized with the test, which involved an 
assessment of repetition velocity in the bench 
press with loads of 50%, 75%, and 90% of 1RM. 
After the first visit, the participants were 
randomized to the three experimental conditions:  
 
 
(a) placebo; (b) caffeine; and (c) control. Before 
every session, the participants were instructed to 
give maximum effort in the exercise tests. A 
minimum of 3 and a maximum of 6 days was 
provided between trials. All testing sessions were 
conducted in the morning hours (between 07:00 
and 09:00 am), and all participants performed the 
trials in a fasted state. Both caffeine and placebo 
were provided in gelatin capsules of identical 
appearance, 60 minutes before starting the testing 
session. Caffeine was provided in the dose of 6 
mg/kg, while the placebo contained 6 mg/kg of 
dextrose. In the control condition, the participants 
came to the laboratory and waited for 60 minutes 
before beginning the testing session; however, 
they did not ingest any capsule. 
Participants 
Power analysis was performed using 
G*Power (version 3.1.9.2, University Düsseldorf, 
Germany) and the following parameters: 
“ANOVA, repeated measures, within factors” 
was assumed as the statistical test, expected effect 
size (f) for repetition velocity was 0.15, alpha = 
0.05, the statistical power = 80%, r = 0.85, one 
group of participants, and three experimental 
conditions. The power analysis indicated that a 
sample of 23 participants was required for this 
study. To account for potential drop-outs, we 
recruited 26 participants. All participants were 
“resistance-trained,” defined as having a 
minimum of one year of resistance training 
experience and being able to lift at least 100% of 
their body mass in the bench press exercise. None 
of the participants used targeted caffeine 
supplementation in the last six months before the 
study commenced. One participant experienced 
nausea after caffeine ingestion and could not 
complete the testing protocol. Therefore, 25 
participants were included in the analysis (mean ± 
SD: age 23 ± 2 years; height 183 ± 7 cm; body mass 
83 ± 11 kg; habitual caffeine intake: 1.0 ± 1.2 
mg/kg/day, range: 0 to 4.4 mg/kg/day; 1RM in the 
bench press: 104.2 ± 15.7 kg). Ethical approval for 
the study was obtained from the Committee for 
Scientific Research and Ethics of the Faculty of 
Kinesiology at the University of Zagreb (approval 
number: 48/2019). Additionally, participants were 
informed about the study risks and benefits, and 
all provided written informed consent. 
Exercise tests 
Fifty minutes after capsule ingestion (placebo  
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or caffeine) or after passive rest (control 
condition), the participants performed ten 
minutes of self-selected warm-up. In each session, 
the participants were instructed to keep the 
warm-up consistent. In the three experimental 
conditions, mean repetition velocity was assessed 
using a valid and reliable PowerLift mobile phone 
application (Balsalobre-Fernández et al. 2017). 
This device has high test-retest reliability, as 
demonstrated by intra-class correlation 
coefficients for mean repetition velocity that 
ranged from 0.93 to 0.99 (Balsalobre-Fernández et 
al. 2017). The PowerLift mobile phone application 
allows: 
1. Video recording of the lift in slow motion, 
2. Frame-by-frame inspection of the 
recorded video material, 
3. Manual selection of the beginning and the 
end of the concentric portion of the 
movement. 
The push-off phase was considered as the 
beginning of the movement. The end of the 
movement was considered the moment when the 
participants fully extended the elbows. The 
eccentric phase lasted two seconds in each 
repetition and the participants were instructed to 
perform the eccentric action in a controlled 
manner. The application calculated the time (in 
m/s) between two frames and provided mean 
repetition velocity data. In each session, the 
participants performed two, one, and one 
repetition of the bench press exercise with loads 
of 50%, 75%, and 90% of their 1RM, respectively. 
For 50% of 1RM, the better repetition, in the 
context of higher mean velocity, was used for the 
analysis. All repetitions were carried out with 
maximal intended concentric velocity. A three-
minute rest interval was provided between sets or 
loads. 
Assessment of blinding 
The effectiveness of the blinding was 
tested pre- and post-exercise in the placebo and 
caffeine trials (Saunders et al. 2017). For this 
assessment, we asked participants the following 
question: “Which supplement do you think you 
have ingested?” This question had three possible 
answers: (a) “caffeine”; (b) “placebo”; (c) “do not 
know”. 
Statistical analysis 
The differences between the caffeine, 
placebo, and control trials in mean velocity at  
 
 
50%, 75%, and 90% of 1RM were examined using 
one-way repeated measures ANOVA. In the case 
of a significant main effect, post hoc analysis was 
performed using pairwise comparisons between 
each condition with a paired t-test. We initially set 
the statistical significance threshold at p < 0.05. 
However, because of the multiple comparisons, 
the Holm-Bonferroni correction was used to 
adjust the alpha value. Based on the rank of p-
values, the statistical significance threshold was 
set at 0.05, 0.025, and 0.017 for rank 3, 2, and 1, 
respectively. Hedges’ g effect size (ES) for 
repeated measures was calculated and presented 
with their respective 95% confidence intervals 
(CI). ES interpretation was based on the following 
classification: “trivial” <0.20, “small” 0.20–0.49, 
“moderate” 0.50–0.79, and “large” ≥0.80. The 
effectiveness of the blinding was explored using 
the Bang’s Blinding Index (Bang et al. 2004). 
Values in this index range from –1 (opposite 
guessing) to 1 (complete lack of blinding). Here, 
these data are reported as a percentage of 
individuals who identified the correct treatment 
condition beyond chance. All analyses were 
performed using the Statistica software (version 
13.4.0.14; TIBCO Software Inc., Palo Alto, CA, 
USA). 
Results  
Mean velocity outcomes 
The results of the one-way repeated 
measures ANOVA for mean velocity at 50% of 
1RM indicated a significant main effect of 
condition, p < 0.009. There was no significant 
difference between placebo and caffeine (ES = 
0.09; 95% CI: –0.10, 0.28; p = 0.478; alpha = 0.05; 
+1.2%; Table 1 and Table 2), or between placebo 
and control conditions (ES = 0.19; 95% CI: 0.00, 
0.42; p = 0.036; alpha = 0.025; +2.5%). There was a 
significant effect of caffeine compared to control 
(ES = 0.29; 95% CI: 0.09, 0.50; p = 0.003; alpha = 
0.017; +3.7%). 
The results of the one-way repeated 
measures ANOVA for mean velocity at 75% of 
1RM indicated a significant main effect of 
condition, p < 0.001. There was no significant 
difference between placebo and control (ES = 0.00; 
95% CI: –0.20, 0.20; p = 0.666; alpha = 0.05; 0.0%). 
There was a significant effect of caffeine 
compared to placebo (ES = 0.34; 95% CI: 0.12, 0.58; 
p = 0.001; alpha = 0.025; +5.7%), and compared to  
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control (ES = 0.32; 95% CI: 0.13, 0.53; p < 0.001; 
alpha = 0.017; +5.7%).  
The results of the one-way repeated 
measures ANOVA for mean velocity at 90% of 
1RM indicated a significant main effect of 
condition, p < 0.001. There was no significant 
difference between placebo and control (ES = 0.11; 
95% CI: –0.06, 0.29; p = 0.376; alpha = 0.05; +3.0%). 
There was a significant effect of caffeine 
compared to placebo (ES = 0.36; 95% CI: 0.15, 0.60; 




to control (ES = 0.46; 95% CI: 0.22, 0.71; p < 0.001; 
alpha = 0.017; +12.1%).  
Effectiveness of blinding  
When evaluated pre-exercise, 20% and 
44% of all participants identified caffeine and 
placebo trials beyond random chance, 
respectively. When evaluated post-exercise, 28% 
and 52% of all participants identified caffeine and 






Mean repetition velocity at 50%, 75%, and 90% of one-repetition maximum (1RM)  
in the three experimental conditions. 
Variable Caffeine trial Placebo trial Control trial 
Mean repetition velocity at 50% 1RM (m/s) 0.83 ± 0.11 0.82 ± 0.11 0.80 ± 0.09 
Mean repetition velocity at 75% 1RM (m/s) 0.56 ± 0.09 0.53 ± 0.08 0.53 ± 0.09 
Mean repetition velocity at 90% 1RM (m/s) 0.37 ± 0.08 0.34 ± 0.08 0.33 ± 0.09 





All pairwise comparisons and their p-values and the adjusted p-values using  
the Holm-Bonferroni correction. For each outcome, p-values are ranked from highest to lowest 








Mean velocity at 50% of 
1RM 
Caffeine vs. placebo 0.478 3 0.05 
Placebo vs. control 0.036 2 0.025 
Caffeine vs. control 0.003 1 0.017 
Mean velocity at 75% of 
1RM 
Placebo vs. control 0.666 3 0.05 
Caffeine vs. placebo 0.001 2 0.025 
Caffeine vs. control 0.0003 1 0.017 
Mean velocity at 90% of 
1RM 
Placebo vs. control 0.376 3 0.05 
Caffeine vs. placebo 0.0002 2 0.025 
Caffeine vs. control 0.0001 1 0.017 
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Discussion 
The main finding of this study is that 
caffeine ingestion, compared to placebo, was 
ergogenic for mean velocity in the bench press 
exercise at 75% and 90% of 1RM. When compared 
to the control condition, caffeine ingestion was 
ergogenic for mean velocity across all analyzed 
loads. However, there were no significant 
differences between placebo and control 
conditions, suggesting that isolated placebo 
ingestion may not be ergogenic for mean 
repetition velocity in resistance exercise.  
The results presented herein are not in 
agreement with previous research that explored 
the effects of placebo ingestion on resistance 
exercise-related outcomes. Specifically, Pollo et al. 
(2008) and Duncan et al. (2009) reported that 
placebo ingestion was ergogenic for total work 
and muscle endurance in the leg extension 
exercise, respectively. Additionally, Costa et al. 
(2018) also reported that placebo ingestion, 
coupled with a suggestion that the capsule 
contains caffeine, was ergogenic for movement 
velocity at 50%, but not at 60%, 70%, or 80% of 
1RM. These results are in contrast to those 
presented herein likely because of the 
methodological differences in the studies. 
Specifically, previous research used a design 
whereby a placebo was provided to the 
participants together with the suggestion that the 
capsules contained caffeine (even though caffeine 
was not ingested in any of the trials). However, in 
the present study, we used a double-blind study 
design, where neither the investigators nor the 
participants knew the content of the capsules, and 
there were no suggestions provided to the 
participants that may influence their exercise 
performance. 
Caffeine ingestion may result in side-
effects (both positive and negative), such as 
increased heart rate, headache, and increased 
focus (Juliano and Griffiths, 2004). Due to these 
side-effects, some participants may be able to 
correctly identify the content of the capsules. This 
is important to consider as correct supplement 
identification may influence the outcomes of an 
exercise task and lead to bias in the results, 
despite the “double-blind” study design 
(Saunders et al. 2016). Therefore, for studies that 
examine the effects of caffeine on exercise 
performance, it is essential to explore the  
 
effectiveness of the blinding of the participants to  
the caffeine and placebo trials. Many studies do 
not even perform this procedure (Grgic, 2018; 
Grgic et al. 2018). Some studies that also used 6 
mg/kg of caffeine reported that 75% to 92% of all 
participants were able to correctly identify the 
caffeine trial (Carr et al. 2011; Tarnopolsky and 
Cupido, 2000). In this study, the blinding 
effectiveness was high, given that only 20% to 
28% of the participants were able to correctly 
identify the caffeine condition beyond random 
chance. Given the effective blinding and the lack 
of the ergogenic effects of placebo ingestion, it 
seems that the improvements following caffeine 
ingestion are mainly due to caffeine's 
physiological effects, such as increased motor unit 
recruitment (Bazzucchi et al. 2011). The study by 
Tallis et al. (2016) further confirms this idea. Here, 
the participants were tested on four occasions: (a) 
"told caffeine – given caffeine"; (b) "told caffeine – 
given placebo"; (c) "told placebo – given placebo"; 
and (d) "told placebo – given caffeine". 
Improvement in isokinetic torque was observed 
only on the two occasions when the participants 
truly ingested caffeine (i.e., "told caffeine, given 
caffeine" and "told placebo, given caffeine" 
conditions).  
When assessing the effects of caffeine on 
repetition velocity, it is important to use different 
loads, as some authors have hypothesized that 
caffeine's effects on repetition velocity might be 
external-load-dependent (Grgic et al. 2019). 
Interestingly, the ES of caffeine (when compared 
to both control and placebo trials) increased with 
the increases in external load lifted. At 50%, 75%, 
and 90% of 1RM, ES ranged from 0.19–0.29, 0.32–
0.34, and 0.36–0.46, respectively. These results 
suggest that the ES of caffeine on repetition 
velocity is the greatest when the force production 
requirements are highest. We observed a similar 
pattern in our recent study where ES ranged from 
0.20–0.29 for loads up 50% of 1RM, 0.36–0.50 at 
75% 1RM, and 0.57–0.61 at 90% 1RM (Grgic et al. 
2020b). Nevertheless, it warrants mention that the 
95% CIs in the present study somewhat 
overlapped between the analyses for different 
loads and the loads used in each testing session 
were increased from lowest to highest (i.e., the 
order of loads was not randomized). These 
limitations make drawing firm conclusions on the 
relationship between caffeine ES and load lifted 
difficult. 
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There are several limitations to the 
present study that need to be considered when 
drawing practical inferences. Even though the 
blinding can generally be classified as effective, 
we should also consider that the number of 
participants that correctly identified caffeine or 
placebo was higher when the blinding was 
evaluated post-exercise vs. pre-exercise. In this 
context, an argument can be made that the pre-
exercise responses are more important, because 
the improvements during the testing session (or 
lack thereof) may influence the post-exercise 
responses. We instructed the participants to 
provide maximum effort in each session. 
However, there might have been a lack of 
motivation in some participants in the control 
condition as there was no substance ingestion 
associated with this trial. The participants 
performed all testing sessions in a fasted state, 
which is not a very common practice for most 
individuals performing resistance exercise and is 
not in accord with the current sports nutrition 
guidelines (Aird et al. 2018). This also has 
relevance because caffeine's effects may be smaller 
when caffeine is ingested in a fed vs. fasted state 
(McLellan et al. 2016). Additionally, given that the  
 
 
study was conducted in a sample of young 
resistance-trained men, the findings cannot 
necessarily be generalized to older populations, 
women, and those who are untrained. Finally, the 
included participants were generally “low” 
habitual caffeine users with a median intake of 0.6 
mg/kg/day (Filip et al. 2020). Therefore, future 
research is needed to explore this topic among 
participants with higher habitual caffeine intake. 
Conclusion 
In this study, we found that caffeine 
ingestion, compared to placebo, provided an 
ergogenic effect on mean velocity in the bench 
press exercise at loads of 75% and 90% of 1RM. 
When compared to the control condition, caffeine 
ingestion was ergogenic for mean velocity across 
all analyzed loads. No significant differences were 
found between placebo and control conditions. 
Given that the blinding of the participants was 
generally effective, and that there were no 
significant ergogenic effects of placebo ingestion, 
it seems that the improvements in performance 
following caffeine ingestion can be mainly 
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